NCT03519971 2025-10-28
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute